the investigations showed that : 1 ) intravenous cinnarazin produced in patients with cerebrovascular diseases good effects , particularly in cases of transient circulatory disturbances in the brain , particularly in cases of atrial rhythm disorders , 2 ) particularly evident rheoencephalographic changes developed after from 10 to 20 minutes after cinnarazin administration intravenously and were recorded during 2 hours , according to clinical data the effect of the treatment persisted during three months after completion of treatment .
C0007820
cerebrovascular diseases
C0006104
brain